Join us to hear from Dr. George Davey Smith from University of Bristol on "Mendelian Randomization – what it was, what it is, and what it should become." 🗓️ March 7, 2025 | 12-1 pm ET | bit.ly/4ke7DjK | Open to all george davey smith #StatisticalGenetics #GeneticEpidemiology #STAGE

I for one am shocked that the market isn’t responding better to 16th century mercantilist trade policies.

Liveposting on Bluesky: Keith Flaherty: Targets and therapeutics in need of functional insights to guide drug development in solid tumors #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Jeffrey Tyner: Functional omics for novel therapeutic combinations in myeloid malignancies #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Coleman Lindsley: Dyanmic assessment in leukemia. What is minimal residual disease and does it matter? #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Sascha Dietrich: Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: AK Eisfeld: Genomic inclusivity in AML #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: @jesseboehm: AscitesPredict: evaluating therapeutic efficacy using rapid ex vivo high dimensional morphology profiling #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: @PeterHorak_MD: Integrative multi-omics profiling of rare cancers: charting new pathways for clinical translation #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: David Tuveson: Organoid models of pancreatic cancer #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Soragni:Lab: Patient-derived tumor organoid models to identify drug susceptibilities in rare cancers #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Chris Jones: Cell states and plasticity define drug sensitivity and resistance in paediatric-type diffuse high-grade glioma patient-derived models #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Bernhard Küster: Phosphoproteome profiling for clinical decision-making in molecular tumor boards #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Thomas Kislinger: Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Celeste Simon: Exploiting kidney cancer cholesterol metabolism for beneficial new therapies #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Taran Gujral: Harnessing patient tissues and AI for rapid, personalized cancer therapy discovery #AACRprecmed25 bsky.app/profile/michae…

Liveposting on Bluesky: Eli Van Allen: The precision cancer medicine challenge: How do we translate all prior knowledge, and all knowledge about a cancer patient at one point in time to make optimal clinical decision? #AACRprecmed25 bsky.app/profile/michae…

loser

This one is burned into my brain

To be fair, 'Eliezer' is a tough one